A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Loading organization
Organization name
A profile about the people, projects and experiences behind their work. Discover their career, contributions and connections.
Backed byDetails being loaded
Cosigned byDetails being loaded
Team on CosignDetails being loaded
Team
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Cosigns Received
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Celeris Therapeutics
Celeris Therapeutics is going to solve the R&D shortcomings as the pioneer in AI-driven PIC (proximity-inducing compounds) design using an innovative closed-loop engine (CelerisTx One™ platform) to develop new chemical entities (NCEs) that degrade proteins by establishing proximity to endogenous cellular mechanisms. The solutions include machine learning-driven prediction of interactions, generative design, optimization of molecular properties, and automation of laboratory devices.
CelerisTx's drug pipeline is focused on CNS and oncology, targeting unmet medical needs. We also co-develop therapeutics with pharmaceutical and biotech companies.
CelerisTx has so far attracted a total of EUR 18 million in committed capital from venture capital funds, which include EIC Fund, Pace Ventures Enigma, i&i biotech, Apex Ventures, R42 and longevitytech.fund.
#targetedproteindegradation #degrader #ubiquitinproteasomesystem #machinelearning #CelerisOne #proximityinducingcompounds #PICs
Backed by
Loading investors
Founders
Loading founders
Cosigned by
Loading cosigns
Featured roles
Loading featured roles
Team
Loading company relationships
Team
5
Profile nameProfile nameProfile name
Team
5
Profile nameProfile nameProfile name
Loading company cosigns
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.
Profile name
Cosigner name
A thoughtful collaborator who builds great products and supports the people around them.